As AHR and ER exhibit “cross-talk” through a number of mechanisms, with a resultant impact on breast cancer cells (45–47), it is not surprising that human trials have examined chemoprevention of breast cancer (7, 8, 48). The gene discussed is ESR1; the disease is breast carcinoma.